A Global Breakthrough in Hair Loss Treatment
Across the world, hair loss affects roughly 85% of men and about 50% of women at some point, with noticeable signs emerging in the 30s and 40s. In Israel, a new voice in dermatology is turning heads: FoLix, a cutting-edge laser therapy developed by LUMENIS, is being introduced as a safe, non-invasive treatment for hair thinning and loss. The launch by Dr. Lehabit Ackerman’s clinic in Herzliya Pituach signals not just a local milestone but a potential shift in how clinicians approach hair restoration.
Researchers and clinicians emphasize that hair loss can undermine self-esteem and body image, sometimes elevating anxiety and depression, especially among younger people and women. The FoLix treatment promises to address these concerns with a technology that works with the body’s own healing processes rather than relying on drugs, daily topical applications, injections, or surgery.
The FoLix System: How It Works
FoLix is a pioneering fractional non-ablative laser device from a leading name in aesthetic medicine. It delivers focused laser light into the scalp in a way that penetrates deep tissue while sparing the outer skin. This creates controlled micro-injuries that trigger natural repair mechanisms: improved blood flow to the scalp, increased production of growth factors, activation of fibroblasts to boost collagen, and reactivation of dormant hair follicles. An integrated cooling system, known as FoliCool, runs in tandem with the laser to maintain comfort and safety, ensuring the treatment is comfortable with minimal sensation and minimal risk of adverse effects.
Treatment Protocol and Patient Experience
The regimen comprises six sessions, each spaced four weeks apart and lasting about 30 minutes. The procedure is non-invasive—no needles, chemicals, or surgical intervention—and does not require anesthesia. Consequently, patients can return to their daily routines immediately after each session. For optimal, lasting results, doctors typically recommend 2–3 maintenance sessions per year after completing the initial six-session course, tailored to the individual’s condition and physician guidance.
Most patients report a comfortable experience during the procedure, commonly noting a warm sensation or mild tingling. Visible improvements in scalp appearance and hair density usually unfold gradually over the course of the treatment series and continue afterward as the scalp’s biology responds to renewed stimulation.
Clinical Evidence and International Recognition
Preclinical and clinical assessments have demonstrated increases in hair counts and follicle units per square centimeter, along with improved scalp aesthetics after the treatment series. The therapy emphasizes safety and comfort, aligning with modern patient expectations for non-surgical solutions with rapid return-to-normal activities.
FoLix has earned international recognition: in 2025 it received the MedTech Breakthrough Award for “Innovative Technology in Dermatology,” and it was named the “Best Laser for Hair Loss” by the popular NewBeauty magazine. Such awards underscore the device’s potential to reshape both patient outcomes and clinical practice in dermatology and aesthetic medicine.
Expert Insight from Dr. Lehabit Ackerman
“Hair loss is a common issue that often requires a combination of technologies to address it effectively,” says Dr. Ackerman. “With FoLix, we are offering a safe, effective, technology-driven treatment that does not rely on drugs, injections, or surgery. It also shows promise for thinning beards, expanding the spectrum of patients who can benefit.”
What It Means for Patients in Israel and Beyond
The introduction of FoLix in Israel reflects a broader trend toward non-invasive, science-backed hair restoration options. For patients who sought a less disruptive alternative to medications or procedures, FoLix provides an evidence-based pathway that emphasizes comfort, safety, and natural-looking results. The combination of clinical data, physician support, and international recognition positions FoLix as a notable reference in contemporary dermatology and aesthetic medicine.
Looking Ahead
As more clinics adopt this approach, ongoing monitoring and longer-term studies will help refine maintenance strategies and identify which patient groups respond most strongly. For now, FoLix represents a meaningful advancement for anyone dealing with hair loss, thinning hair, or even beard thinning, offering a non-invasive option grounded in modern laser science and clinical excellence.
